 SMC Global Securities Ltd Q2 FY2025-26 consolidated net profit declines to Rs. 20.65 crores
SMC Global Securities Ltd Q2 FY2025-26 consolidated net profit declines to Rs. 20.65 crores Rajoo Engineers Ltd Q2FY26 consolidated profit at Rs. 14.18 crores
Rajoo Engineers Ltd Q2FY26 consolidated profit at Rs. 14.18 crores Inventurus Knowledge Solutions Ltd consolidated Q2 FY2025-26 PAT climbs to Rs. 180.71 crores
Inventurus Knowledge Solutions Ltd consolidated Q2 FY2025-26 PAT climbs to Rs. 180.71 crores IFB Industries Ltd consolidated PAT for Q2FY26 jumps to Rs. 50.79 crores
IFB Industries Ltd consolidated PAT for Q2FY26 jumps to Rs. 50.79 crores Share India Securities Ltd consolidated Q2 FY26 net profit at Rs. 92.91 crores
Share India Securities Ltd consolidated Q2 FY26 net profit at Rs. 92.91 crores 
              Eris Lifesciences Ltd has approved an allotment of 5486 equity shares of Re. 1/- each has been made on 21.04.2018, pursuant to exercise of options under its ESOP-2017 Scheme.
The paid up share capital of the Company has accordingly been increased from Rs. 13,75,00,000 (13,75,00,000 equity shares of Re. 1/- each) to Rs. 13,75,05,486 (13,75,05,486 equity shares of Re. 1/- each).
Shares of Eris Lifesciences Ltd was last trading in BSE at Rs.790.05 as compared to the previous close of Rs. 794.4. The total number of shares traded during the day was 579 in over 47 trades.
The stock hit an intraday high of Rs. 799 and intraday low of 783.2. The net turnover during the day was Rs. 458616.